DealShot: Hillhouse Capital Leads $35M Series B+ Round In Just Biotherapeutics China

Follow Us:

China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis.

Here you can find out where Chinese investors have been investing their money each workday.

CompanyRoundLead InvestorParticipantsSectorHeadquarters
Hangzhou Just BiotherapeuticsSeries B+Hillhouse CapitalTemasek Holdings, Lilly Asia Ventures, ARCH Venture Partners, Taikang Asset, BOCGI Zheshang Capital Co., LtdHealthcareHangzhou
ChezhibaoSeries DGreen Harbor InvestmentPAG, Addor Capital, Gobi PartnersE-commerceNanjing
Bigo LiveSeries DYY Inc.David LiMedia & EntertainmentSingapore
TokenGazerAngel RoundJRR Crypto, Keda GroupBlockchainShanghai
Danke ApartmentSeries B+Tiger Global ManagementChina Media Capital, Gaorong Capital, Joy Capital, Vision Plus Capital, Bertelsmann Asia Investments (BAI), Shenzhen Youjin Investment ManagementReal EstateBeijing
Dujiao ShowSeries ASequoia Capital ChinaMedia & EntertainmentBeijing
OO Eye InstrumentSeries A+Wanxin Jinzhi Scientific Education FundFoxconn Technology GroupHealthcareBeijing
BoniaohuibenAngel RoundHuadan Angel InvestmentLiyuan Venture CapitalEducationHangzhou
TalentCloud InformationSeries APagodaAgricultureNanning
Nanos MedicalSeries BAdvantech Capital, Marathon Venture PartnersMedtronic China Venture FundHealthcareShanghai
HexFuturePre-AChunxiao CapitalEducationBeijing
CoinVoiceAngel RoundJ LabShenzhen Qianhai Kexi Capital ManagementBlockchainGuangzhou
ChewrobotSeries AZongton Capital, Leaguer Venture Capital, Boyaa InteractiveAI & RoboticsShenzhen
CMR SurgicalSeries BZhejiang Silk Road Fund, Escala Capital Investments, LGT, Cambridge Innovation Capital, WatriumAI & RoboticsCambridge
SemiTripAngel RoundCowin CapitalE-commerceGuangzhou
Qmai.cnAngel RoundundisclosedEnterprise servicesHefei

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *